ReviewCancer management and research2023

Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To Date.

Pedro Luiz Serrano Uson Junior et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.